Thursday, March 21, 2019
Lead Pharma Begins Phase I Trials with SAR441169 Candidate Treatment for Psoriasis
Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, achieved a fourth milestone under its license & collaboration agreement with Sanofi, triggering an undisclosed milestone payment. The milestone payment is linked …
Read full story
- Paratek Pharmaceuticals, Inc.
Thursday, August 09, 2018
The Antimicrobials Drug Advisory Committee of the FDA voted in favor of the approval of intravenous (IV) and oral omadacycline for the treatment of acute bacterial skin and skin structure infections (…Read the full story